Grant: Idea to Innovation
McMaster University
$15,000.00
IFlowPlate - A universal platform for vascularizing organoids
EF 2020-21
Résumé
Biological research, which encompasses fundamental research in academic labs, drug discovery in pharmaceutical companies, and clinical research in hospitals requires predictable biological models. In recent years, organoids has emerged and attracted significant attention in academic research as well as in the commercial sectors. Organoids are mini organs that are grown in a dish over time from a single or a small cluster of human stem cells. Though organoids cannot replace humans, they can offer valuable insights into the function of drugs, the mechanism of disease progression, and the process of organ development that cannot be provided by single-cell assay or animal models. However, there is one critical biological component that is missing in all organoids - a perfusable blood vessel network. To solve this problem, we developed a platform (here referred to as IFlowPlate) that can be used to grow an array of perfusable blood vessel network to vascularize organoids on demand
Commercialization of our IFlowPlate platform is to provide academic, pharmaceutical and hospital lab with a more physiological model and a way to probe the model with intravascular perfusion by upgrading existing organoid cultures with vasculatures. We propose to commercialize the IFlowPlate by establishing an ecosystem of collaborators and beta testers around IFlowPlate to continuously validate our product and expand its application. The requested funds for a Market Assessment will provide recommendations and data to enable us to created a product development and business for successful technology transfer and positioning in the market.
Programme
Idea to Innovation
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
556938-2020
Name nom
Zhang, Boyang
Department département
Chemical Engineering
Organization id
27
Institution établissement
McMaster University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2020
Competition year année de concours
2020
Award amount
15000
Program id
I2IPJ
Program name en
Idea to Innovation
Program name fr
De l'idée à l'innovation
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Installment
inst:1 - 1
Partie
1
Nb partie
1
Application title
IFlowPlate - A universal platform for vascularizing organoids
Keyword
NSERC
Application summary
Biological research, which encompasses fundamental research in academic labs, drug discovery in pharmaceutical companies, and clinical research in hospitals requires predictable biological models. In recent years, organoids has emerged and attracted significant attention in academic research as well as in the commercial sectors. Organoids are mini organs that are grown in a dish over time from a single or a small cluster of human stem cells. Though organoids cannot replace humans, they can offer valuable insights into the function of drugs, the mechanism of disease progression, and the process of organ development that cannot be provided by single-cell assay or animal models. However, there is one critical biological component that is missing in all organoids - a perfusable blood vessel network. To solve this problem, we developed a platform (here referred to as IFlowPlate) that can be used to grow an array of perfusable blood vessel network to vascularize organoids on demand
Commercialization of our IFlowPlate platform is to provide academic, pharmaceutical and hospital lab with a more physiological model and a way to probe the model with intravascular perfusion by upgrading existing organoid cultures with vasculatures. We propose to commercialize the IFlowPlate by establishing an ecosystem of collaborators and beta testers around IFlowPlate to continuously validate our product and expand its application. The requested funds for a Market Assessment will provide recommendations and data to enable us to created a product development and business for successful technology transfer and positioning in the market.